Alain Tedgui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alain Tedgui has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ziad Mallat
Department of Medicine, Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
9 shared publications - Jean-François Arnal
Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III Paul Sabatier, CHU Rangueil (University Hospital) de Toulouse, F-31432 Toulouse, France
2 shared publications - Pierre Gourdy
Department of Endocrinology, Diabetology and Nutrition, CHU Toulouse, I2MC UMR1297, INSERM, University of Toulouse, Toulouse, France
2 shared publications S. Lehoux
French Institute of Health and Medical Research
2 shared publicationsA. Billon
French Institute of Health and Medical Research
1 shared publication- Aurelie S. Leroyer
Hematology Department, Center for CardioVascular and Nutrition Research C2VN, Faculty of Pharmacy, Timone Campus, Aix-Marseille University, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de Recherche Pour L’agriculture, L’alimentation et L’environnement (INRAE), 13005 Marseille, France
1 shared publication
Latest Publications
- Open Access
- 7 October 2007
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 77 (3) , 471-480
Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition
We analysed the possible protective role of human endothelial (EPCs) and smooth muscle (SPCs) progenitor cells on atherosclerosis development in apoE−/−RAG2−/− mice. We determined plasma levels of SPCs in coronary patients. ApoE−/−RAG2−/− mice received four intravenous injections of saline, 5 × 105 SPCs, or 5 × 105 EPCs every other week, one (preventive approach) or 12(curative approach) weeks after starting a high fat diet. Derived-SPC levels were quantified from blood mononuclear cells of patients with stable angina (n = 10) and acute coronary syndromes (ACS, n = 9). SPCs reduced atherosclerosis development by 42% (P < 0.001), but had no effect on lesion progression. In the SPC group, collagen and smooth muscle cell content were increased (+80%, P < 0.001, +46%, P < 0.05, respectively), and macrophage content was decreased (−41%, P < 0.05). In the curative approach, macrophage content decreased by 40.5% (P < 0.05) after SPC injection. EPC injection had no effect on atherosclerosis development or progression. Peripheral blood-derived SPC levels were reduced in patients with ACS compared with stable angina patients (P < 0.05). We demonstrate that SPCs limit plaque development and promote changes in plaque composition towards a stable phenotype in mice. Our finding in patients suggests that reduced peripheral blood-derived SPC levels might represent a mechanism contributing to plaque destabilization.
- 7 October 2007
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 77 (3) , 471-480
Open AccessRole of human smooth muscle cell progenitors in atherosclerotic plaque development and composition
We analysed the possible protective role of human endothelial (EPCs) and smooth muscle (SPCs) progenitor cells on atherosclerosis development in apoE−/−RAG2−/− mice. We determined plasma levels of SPCs in coronary patients. ApoE−/−RAG2−/− mice received four intravenous injections of saline, 5 × 105 SPCs, or 5 × 105 EPCs every other week, one (preventive approach) or 12(curative approach) weeks after starting a high fat diet. Derived-SPC levels were quantified from blood mononuclear cells of patients with stable angina (n = 10) and acute coronary syndromes (ACS, n = 9). SPCs reduced atherosclerosis development by 42% (P < 0.001), but had no effect on lesion progression. In the SPC group, collagen and smooth muscle cell content were increased (+80%, P < 0.001, +46%, P < 0.05, respectively), and macrophage content was decreased (−41%, P < 0.05). In the curative approach, macrophage content decreased by 40.5% (P < 0.05) after SPC injection. EPC injection had no effect on atherosclerosis development or progression. Peripheral blood-derived SPC levels were reduced in patients with ACS compared with stable angina patients (P < 0.05). We demonstrate that SPCs limit plaque development and promote changes in plaque composition towards a stable phenotype in mice. Our finding in patients suggests that reduced peripheral blood-derived SPC levels might represent a mechanism contributing to plaque destabilization.
- 1 October 2006
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 67 (5) , 385-386
CO15 - Rôle inattendu de la NO synthase endothéliale dans l’effet accélérateur du 17bêta-estradiol sur la réendothélialisation et la signalisation membranaire à court terme
- 1 October 2006
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 67 (5) , 385-386
CO15 - Rôle inattendu de la NO synthase endothéliale dans l’effet accélérateur du 17bêta-estradiol sur la réendothélialisation et la signalisation membranaire à court terme
- Top Cited PapersOpen Access
- 1 April 2006
- Published by American Physiological Society in Physiological Reviews
- Vol. 86 (2) , 515-581
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive immunoinflammatory mechanisms are involved. Inflammation is central at all stages of atherosclerosis. It is implicated in the formation of early fatty streaks, when the endothelium is activated and expresses chemokines and adhesion molecules leading to monocyte/lymphocyte recruitment and infiltration into the subendothelium. It also acts at the onset of adverse clinical vascular events, when activated cells within the plaque secrete matrix proteases that degrade extracellular matrix proteins and weaken the fibrous cap, leading to rupture and thrombus formation. Cells involved in the atherosclerotic process secrete and are activated by soluble factors, known as cytokines. Important recent advances in the comprehension of the mechanisms of atherosclerosis provided evidence that the immunoinflammatory response in atherosclerosis is modulated by regulatory pathways, in which the two anti-inflammatory cytokines interleukin-10 and transforming growth factor-β play a critical role. The purpose of this review is to bring together the current information concerning the role of cytokines in the development, progression, and complications of atherosclerosis. Specific emphasis is placed on the contribution of pro- and anti-inflammatory cytokines to pathogenic (innate and adaptive) and regulatory immunity in the context of atherosclerosis. Based on our current knowledge of the role of cytokines in atherosclerosis, we propose some novel therapeutic strategies to combat this disease. In addition, we discuss the potential of circulating cytokine levels as biomarkers of coronary artery disease.
- 1 April 2006
- Published by American Physiological Society in Physiological Reviews
- Vol. 86 (2) , 515-581
Top Cited PapersOpen AccessCytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive immunoinflammatory mechanisms are involved. Inflammation is central at all stages of atherosclerosis. It is implicated in the formation of early fatty streaks, when the endothelium is activated and expresses chemokines and adhesion molecules leading to monocyte/lymphocyte recruitment and infiltration into the subendothelium. It also acts at the onset of adverse clinical vascular events, when activated cells within the plaque secrete matrix proteases that degrade extracellular matrix proteins and weaken the fibrous cap, leading to rupture and thrombus formation. Cells involved in the atherosclerotic process secrete and are activated by soluble factors, known as cytokines. Important recent advances in the comprehension of the mechanisms of atherosclerosis provided evidence that the immunoinflammatory response in atherosclerosis is modulated by regulatory pathways, in which the two anti-inflammatory cytokines interleukin-10 and transforming growth factor-β play a critical role. The purpose of this review is to bring together the current information concerning the role of cytokines in the development, progression, and complications of atherosclerosis. Specific emphasis is placed on the contribution of pro- and anti-inflammatory cytokines to pathogenic (innate and adaptive) and regulatory immunity in the context of atherosclerosis. Based on our current knowledge of the role of cytokines in atherosclerosis, we propose some novel therapeutic strategies to combat this disease. In addition, we discuss the potential of circulating cytokine levels as biomarkers of coronary artery disease.
- 23 February 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (4) , 381-392
Molecular mechanisms of the vascular responses to haemodynamic forces
: Blood vessels are permanently subjected to mechanical forces in the form of stretch, encompassing cyclic mechanical strain due to the pulsatile nature of blood flow and shear stress. Significant variations in mechanical forces, of physiological or physiopathological nature, occur in vivo. These are accompanied by phenotypical modulation of smooth muscle cells and endothelial cells, producing structural modifications of the arterial wall. In all the cases, vascular remodelling can be allotted to a modification of the tensional strain or shear, and underlie a trend to reestablish baseline mechanical conditions. Vascular cells are equipped with numerous receptors that allow them to detect and respond to the mechanical forces generated by pressure and shear stress. The cytoskeleton and other structural components have an established role in mechanotransduction, being able to transmit and modulate tension within the cell via focal adhesion sites, integrins, cellular junctions and the extracellular matrix. Mechanical forces also initiate complex signal transduction cascades, including nuclear factor‐κB and mitogen‐activated protein kinase pathways, leading to functional changes within the cell.
- 23 February 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (4) , 381-392
Molecular mechanisms of the vascular responses to haemodynamic forces
: Blood vessels are permanently subjected to mechanical forces in the form of stretch, encompassing cyclic mechanical strain due to the pulsatile nature of blood flow and shear stress. Significant variations in mechanical forces, of physiological or physiopathological nature, occur in vivo. These are accompanied by phenotypical modulation of smooth muscle cells and endothelial cells, producing structural modifications of the arterial wall. In all the cases, vascular remodelling can be allotted to a modification of the tensional strain or shear, and underlie a trend to reestablish baseline mechanical conditions. Vascular cells are equipped with numerous receptors that allow them to detect and respond to the mechanical forces generated by pressure and shear stress. The cytoskeleton and other structural components have an established role in mechanotransduction, being able to transmit and modulate tension within the cell via focal adhesion sites, integrins, cellular junctions and the extracellular matrix. Mechanical forces also initiate complex signal transduction cascades, including nuclear factor‐κB and mitogen‐activated protein kinase pathways, leading to functional changes within the cell.
- 15 March 2004
- Published by EDP Sciences in médecine/sciences
- Vol. 20 (3) , 298-303
Apoptose et syndromes coronariens aigus
- 15 March 2004
- Published by EDP Sciences in médecine/sciences
- Vol. 20 (3) , 298-303
Apoptose et syndromes coronariens aigus
- 1 June 2003
- Vol. 96 (6) , 671-5
Apoptosis, a major determinant of atherothrombosis.
Clinical manifestations of atherosclerosis are the consequences of atherosclerotic plaque rupture which triggers thrombus formation. Tissue factor (TF) is a key element in the initiation of the coagulation cascade and is crucial in thrombus formation following plaque disruption. TF activity is highly dependent on the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed on the cell surface during apoptotic death conferring a potent procoagulant activity to the apoptotic cell. Apoptosis occurs in the human atherosclerotic plaque, and shed membrane apoptotic microparticles rich in PS are produced in considerable amounts within the lipid core. These microparticles carry almost all TF activity and are responsible for the procoagulant activity of the plaque. Moreover, luminal endothelial cell apoptosis might be responsible for thrombus formation on eroded plaques without rupture. Apoptosis might also play a major role in blood thrombogenicity via circulating procoagulant microparticles that are found at high levels in patients with acute coronary syndromes.
- 1 June 2003
- Vol. 96 (6) , 671-5
Apoptosis, a major determinant of atherothrombosis.
Clinical manifestations of atherosclerosis are the consequences of atherosclerotic plaque rupture which triggers thrombus formation. Tissue factor (TF) is a key element in the initiation of the coagulation cascade and is crucial in thrombus formation following plaque disruption. TF activity is highly dependent on the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed on the cell surface during apoptotic death conferring a potent procoagulant activity to the apoptotic cell. Apoptosis occurs in the human atherosclerotic plaque, and shed membrane apoptotic microparticles rich in PS are produced in considerable amounts within the lipid core. These microparticles carry almost all TF activity and are responsible for the procoagulant activity of the plaque. Moreover, luminal endothelial cell apoptosis might be responsible for thrombus formation on eroded plaques without rupture. Apoptosis might also play a major role in blood thrombogenicity via circulating procoagulant microparticles that are found at high levels in patients with acute coronary syndromes.
- 1 January 2001
- Published by INIST-CNRS in médecine/sciences
- Vol. 17 (2) , 162
Athérosclérose et inflammation.
- 1 January 2001
- Published by INIST-CNRS in médecine/sciences
- Vol. 17 (2) , 162
Athérosclérose et inflammation.
- 1 December 1999
- Vol. 49 (19) , 2081-6
[Atherosclerotic plaque formation].
Atherosclerotic plaque formation involves 5 steps: 1. low density lipoprotein (LDL) accumulation in the intima; 2. oxidation of LDL; 3. recruitment of monocytes-macrophages; 4. uptake of oxidized LDL by macrophage scavenger receptors, and transformation of macrophages into foam cells; 5. formation of a fibrous cap containing smooth muscle cells, which permits stabilization of the plaque. At each step of this process, inflammatory cytokines are implicated making the atherosclerotic process a chronic inflammatory disease.
- 1 December 1999
- Vol. 49 (19) , 2081-6
[Atherosclerotic plaque formation].
Atherosclerotic plaque formation involves 5 steps: 1. low density lipoprotein (LDL) accumulation in the intima; 2. oxidation of LDL; 3. recruitment of monocytes-macrophages; 4. uptake of oxidized LDL by macrophage scavenger receptors, and transformation of macrophages into foam cells; 5. formation of a fibrous cap containing smooth muscle cells, which permits stabilization of the plaque. At each step of this process, inflammatory cytokines are implicated making the atherosclerotic process a chronic inflammatory disease.
- 27 April 1999
- Vol. 54 (1) , 167-70
[Apoptosis and vascular remodeling].
Cell death by apoptosis plays a major role in the homeostasis of the vascular system. Apoptosis of vascular cells, and of endothelial and smooth muscle cells, can be triggered by intrinsic signals related to the cell differentiation phenotype, or by extrinsic signals, including free radicals, inflammatory cytokines or oxidized LDL. Apoptosis contributes to normal physiological modelling of arteries after birth as well as to capillary rarefaction occurring during ontogenic development. Apoptotic processes have been found in several pathological conditions, including atherosclerosis, hypertension or restenosis following percutaneous transluminal angioplasty. However, a direct causal relationship between apoptosis and occurrence of these afflictions remains to be established.
- 27 April 1999
- Vol. 54 (1) , 167-70
[Apoptosis and vascular remodeling].
Cell death by apoptosis plays a major role in the homeostasis of the vascular system. Apoptosis of vascular cells, and of endothelial and smooth muscle cells, can be triggered by intrinsic signals related to the cell differentiation phenotype, or by extrinsic signals, including free radicals, inflammatory cytokines or oxidized LDL. Apoptosis contributes to normal physiological modelling of arteries after birth as well as to capillary rarefaction occurring during ontogenic development. Apoptotic processes have been found in several pathological conditions, including atherosclerosis, hypertension or restenosis following percutaneous transluminal angioplasty. However, a direct causal relationship between apoptosis and occurrence of these afflictions remains to be established.